Last year, Summit Therapeutics ( SMMT 1.31%) was one of the stars of the biotech industry. The company's shares soared ...

Innovent and HUTCHMED received conditional approval for the combo in endometrial cancer from China’s NMPA last year.

Canada’s foreign minister said the government would continue to ask for leniency from China for other Canadians in similar ...

China health care companies received a significant reprieve in terms of geopolitical risks when the US Senate declined to ...

American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

Roxadustat is approved in China, Europe, Japan ... the enrollment and results from ongoing and potential future clinical trials, and other matters that are described in FibroGen’s most recent ...

A federal judge has blocked the cuts while lawsuits move through the courts but it has caused uncertainty and anxiety among ...

VCG. China plans to expand its institutional opening-up trial program at the nation's pilot free trade zones (FTZ), which is ai ...

The number of people prosecuted for spying for Beijing has risen sharply, with retired and serving members of Taiwan’s ...

The assistance of an automatic quality control system improves adenoma detection rates among colonoscopists classified as ...